Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 10, 1997, Pages 1125-1131

  Rosso, S M ^a   Van Dekken, H ^a   Krishnadath, K K ^a   Alers, J C ^a   Kros, J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Astrocytoma; Cytogenetics; Genetic alterations; Glioma; Oligodendroglioma; Tumor progression

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; ARTICLE; ASTROCYTOMA; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERPHASE; MALE; NUMERICAL CHROMOSOME ABERRATION; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR RECURRENCE;

EID: 0030883547     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199710000-00006     Document Type: Article

References (39)

1. Laws ER. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984;61:665-73
2. Vecht CJ, Avezaat CJJ, van Putten WLJ, Eykenboom WH, Stefanko SZ. The influence of the extent of surgery on the postoperative neurological function and survival in malignant glioma. J Neurol Neurosurg Psych 1990;53:466-71
3. Cairncross JG, MacDonald DR. Succesfull chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360-64
4. Cairncross JG, MacDonald D, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994;12:2013-21
5. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992; 76:741-45
6. Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993;32:365-70
7. Fults D, Tippets RH, Thomas GA, Nakamura Y, White R. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 1989;49:6572-77
8. Griffin CA, Long PP, Carson BS, Brem H. Chromosome abnormalities in low-grade central nervous tumours. Cancer Genet Cytogenet 1992;60:67-73
9. Bigner SH, Mark J, Burger PC, et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 1988;88:405-11
10. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-21
11. Bello MJ, De Campos JM, Kusak MH, et al. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP analyses. Cancer Genet Cytogenet 1994;72:55-58
12. Magnani I, Guerneri S, Polio B, et al. Increasing complexity of the karyotype in 50 human gliomas: Progressive evolution and de novo occurrence of cytogenetic alterations. Cancer Genet Cytogenet 1994;75:77-89
13. Sonoda Y, Iizuka M, Yasuda J, et al. Loss of heterozygosity at 11p15 in malignant gliomas. Cancer Res 1995;55:2166-68
14. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-90
15. Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early genetic events in oligodendroglial tumors. Int J Cancer 1995;64:207-10
16. von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 1992;52:4277-79
17. von Deimling A, Nagel J, Bender B, et al. Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 1994;57:676-80
18. Rubio MP, Correa KM, Ueki K, et al. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HCR. Cancer Res 1994;54:4760-63
19. von Deimling A, Bender B, Jahnke R, et al. Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q. Cancer Res 1994;54:1397-1401
20. Ritland SR, Ganju V, Jenkins RB. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chrom Cancer 1995;12:277-82
21. Bello MJ, Vaquero J, de Campos JM, et al. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994;57:172-75
22. Bello MJ, Leone PE, Nebrada P, et al. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995;83:160-64
23. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54:91-95
24. Kleihues P, Burger PC, Scheithauer BW, eds. Histological typing of tumors of the central nervous system. Internat Histol Classification of Tumors, 2nd ed. Geneva: WHO, 1993
25. Alers JC, van Dekken H. Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization. Progr Histochem Cytochem 1996;31(3)
26. Kerstens HMJ, Poddighe PJ, Hanselaar AGJM. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995;43:347-52
27. Raap AK, van de Corput MP, Vervenne RA, van Gijlswijk RP, Tanke HJ, Wiegant J. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin-or fluorochrome tyramides. Hum Mol Genet 1995;4:529-34
28. Fong C-T, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 1989;86:3753-57
29. Simon D, Knowles B, Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 1991;6:765-70
30. Bieche I, Champeme MH, Matifas F, Cropp CS, Callahan R, Liderau R. Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 1993;53:1990-94
31. Lindblom A, Ruttledge M, Collins VP, Nordenskjold M, Dumanski JP. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 1994;56:354-57
32. Schröck E, Thiel G, Lozanova T, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 1994;144:1203-18
33. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S. On trisomy of chromosome 7 in human gliomas. Cancer Genet Cytogenet 1987;29:323-26
34. Jenkins RB, Kimmel DW, Moertel CA, et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 1989;39:253-79
35. Thiel G, Losanowa T, Kintzel, et al. Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 1992;58:109-20
36. Fults D, Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chrom Cancer 1993;7:173-77
37. Rasheed BKA, McLendon RE, Friedman HS, et al. Chromosome 10 deletion mapping in human gliomas: A common deletion in region 10q25. Oncogene 1995;10:2243-46
38. Karlbom AE, James CD, Boethius J, et al. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993;92:169-74
39. Schröck E, Blume C, Meffert MC, et al. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studies by comparative genomic hybridization. Genes Chrom Cancer 1996;15: 199-205